Literature DB >> 32241533

Novel Devices in Heart Failure: BAT, Atrial Shunts, and Phrenic Nerve Stimulation.

Emily P Zeitler1, William T Abraham2.   

Abstract

The substantial burden of heart failure has inspired innovation in medical device development for decades, and this development continues to be a touchstone in the success story of combined medical and device therapy. Recently, baroreflex activation therapy, interatrial shunts, and phrenic nerve stimulation have shown promise in treating patients with heart failure. We seek to provide background about the design, function, and early clinical experience with these 3 novel heart failure devices. In addition, an understanding of the individual regulatory journey of these devices, some of which is ongoing, is informative for future device development and clinical use.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  atrial shunt; baroreflex activation therapy; heart failure; implantable devices; phrenic nerve stimulation

Mesh:

Year:  2020        PMID: 32241533     DOI: 10.1016/j.jchf.2019.11.006

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  2 in total

Review 1.  Device-based treatment options for heart failure with preserved ejection fraction.

Authors:  Chihiro Miyagi; Takuma Miyamoto; Jamshid H Karimov; Randall C Starling; Kiyotaka Fukamachi
Journal:  Heart Fail Rev       Date:  2021-01-12       Impact factor: 4.214

2.  RESPONSE: Hybrid Training for Interventional, Heart Failure, and Critical Care Medicine.

Authors:  Navin K Kapur
Journal:  J Am Coll Cardiol       Date:  2020-06-16       Impact factor: 24.094

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.